Stanley-Laman Group’s Theriva Biologics TOVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7	Closed	-$19K	–	275
2018 Q1	$19K	Hold	7	–	–	﹤0.01%	261
2017 Q4	$31K	Hold	7	–	–	0.01%	267
2017 Q3	$56K	Buy	+7	New	+$56K	0.01%	204